Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists

被引:6
|
作者
Leslie, Colin P. [1 ]
Bentley, Jonathan [1 ]
Biagetti, Matteo [1 ]
Contini, Stefania [1 ]
Di Fabio, Romano [1 ]
Donati, Daniele [1 ]
Genski, Thorsten [1 ]
Guery, Sebastien [1 ]
Mazzali, Angelica [1 ]
Merlo, Giancarlo [1 ]
Pizzi, Domenica A. [1 ]
Sacco, Fabiola [1 ]
Seri, Catia [1 ]
Tessari, Michela [1 ]
Zonzini, Laura [1 ]
Caberlotto, Laura [1 ]
机构
[1] GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
关键词
NPY Y5; NEUROPEPTIDE-Y; RECEPTOR ANTAGONISTS; PEPTIDE-YY; DERIVATIVES; LIGANDS;
D O I
10.1016/j.bmcl.2010.08.041
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of trans-8-aminomethyl-1-oxa-3-azaspiro[4.5] decan-2-one derivatives was identified with potent NPY Y5 antagonist activity. Optimization of the original lead furnished compounds 23p and 23u, which combine sub-nanomolar Y5 activity with metabolic stability, oral bioavailability, brain penetration and strong preclinical profile for development. Both compounds significantly inhibited the food intake induced by a Y5 selective agonist with minimal effective doses of 3 mg/kg po. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6103 / 6107
页数:5
相关论文
共 50 条
  • [1] Novel orally active NPY Y5 receptor antagonists: Synthesis and structure-activity relationship of spiroindoline class compounds
    Sakamoto, Toshihiro
    Moriya, Minoru
    Tsuge, Hiroyasu
    Takahashi, Toshiyuki
    Haga, Yuji
    Nonoshita, Katsumasa
    Okamoto, Osamu
    Takahashi, Hirobumi
    Sakuraba, Aya
    Hirohashi, Tomoko
    Shibata, Takunobu
    Kanno, Tetsuya
    Ito, Junko
    Iwaasa, Hisashi
    Gomori, Akira
    Ishihara, Akane
    Fukuroda, Takahiro
    Kanatani, Akio
    Fukami, Takehiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) : 5015 - 5026
  • [2] Discovery of novel orally active and selective ureido-NPY Y5 antagonists
    Li, Guoqing
    Huang, Ying
    Kelly, Joseph
    Stamford, Andrew
    Greenlee, William
    Mullins, Deborra
    Guzzi, Mario
    Zhang, Xiaoping
    Hwa, Joyce J.
    Gao, Jun
    Ghibaudi, Lorraine
    Weihaus, Sam
    Cheng, K. -C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2564 - U2564
  • [3] Design, synthesis and SAR of a novel series of benzimidazoles as potent NPY Y5 antagonists
    Pizzi, Domenica Antonia
    Leslie, Colin Philip
    Mazzali, Angelica
    Seri, Catia
    Biagetti, Matteo
    Bentley, Jonathan
    Genski, Thorsten
    Di Fabio, Romano
    Contini, Stefania
    Sabbatini, Fabio Maria
    Zonzini, Laura
    Caberlotto, Laura
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7120 - 7123
  • [4] Identification of novel and orally active spiroindoline NPY Y5 receptor antagonists
    Sakamoto, Toshihiro
    Moriya, Minoru
    Haga, Yuji
    Takahashi, Toshiyuki
    Shibata, Takunobu
    Okamoto, Osamu
    Nonoshita, Katsumasa
    Kitazawa, Hidefumi
    Hidaka, Masayasu
    Gomori, Akira
    Iwaasa, Hisashi
    Ishihara, Akane
    Kanatani, Akio
    Fukami, Takehiro
    Gao, Ying-Duo
    MacNeil, Douglas J.
    Yang, Lihu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1564 - 1568
  • [5] Synthesis and structure-activity studies of bisheteroaryl guandines as NPY-Y5 antagonists.
    Ramanjulu, J
    Aquino, C
    Palazzo, F
    Heyer, D
    Daniels, A
    Burnette, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U37 - U37
  • [6] Structure-activity relationships within a series of pyrazolopyrimidine NPY-Y1 receptor antagonists.
    Griffith, DA
    Blum, CA
    Carpino, PA
    Cassella, J
    Darrow, JW
    De Lombaert, S
    Hargrove, DM
    Hickman, MA
    Mack, CM
    Maurer, TS
    Sanders, MJ
    Ashton, MA
    Giangiordano, M
    He, P
    Inthavongsay, JK
    Klade, LE
    Lebel, WS
    Martin, KA
    Regan, C
    Rose, CR
    Tran, J
    Vage, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U689 - U689
  • [7] Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists
    Takahashi, Toshiyuki
    Haga, Yuji
    Sakamoto, Toshihiro
    Moriya, Minoru
    Okamoto, Osamu
    Nonoshita, Katsumasa
    Shibata, Takunobu
    Suga, Takuya
    Takahashi, Hirobumi
    Hirohashi, Tomoko
    Sakuraba, Aya
    Gomori, Akira
    Iwaasa, Hisashi
    Ohe, Tomoyuki
    Ishihara, Akane
    Ishii, Yasuyuki
    Kanatani, Akio
    Fukami, Takehiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3511 - 3516
  • [8] Synthesis and structure-activity relationships of trisubstituted phenyl urea derivatives as neuropeptide Y5 receptor antagonists
    Fotsch, C
    Sonnenberg, JD
    Chen, N
    Hale, C
    Karbon, W
    Norman, MH
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (14) : 2344 - 2356
  • [9] Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists
    Norman, MH
    Chen, N
    Chen, ZD
    Fotsch, C
    Hale, C
    Han, NH
    Hurt, R
    Jenkins, T
    Kincaid, J
    Liu, LB
    Lu, YL
    Moreno, O
    Santora, VJ
    Sonnenberg, JD
    Karbon, W
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) : 4288 - 4312
  • [10] Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
    Zarrinmayeh, H
    Zimmerman, DM
    Cantrell, BE
    Schober, DA
    Bruns, RF
    Gackenheimer, SL
    Ornstein, PL
    Hipskind, PA
    Britton, TC
    Gehlert, DR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (05) : 647 - 652